US 10889834
Methods and compositions for enhancing targeted transgene integration
granted A61KA61K31/4745A61K31/7048
Quick answer
US patent 10889834 (Methods and compositions for enhancing targeted transgene integration) held by Sangamo Therapeutics, Inc. expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue Jan 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/4745, A61K31/7048, A61K48/00